IQV IQVIA Holdings Inc.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.…
Industry Peers
Diagnostics & ResearchKey Statistics
About IQVIA Holdings (NYSE: IQV)
›
IQVIA Holdings (NYSE: IQV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 95,000 employees.
The shares were at 250.55 USD on 19 November 2026, up 13.6% over 52 weeks. Its 52-week range is 154.50 USD to 284.50 USD: the price is 11.9% below the high and 62.2% above the low.
At a market capitalisation of 41.29B USD, it trades at 30.5 times trailing earnings and 17.6 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 34.6, a discount of 12% for IQV.
IQVIA Holdings reports return on equity of 20.9%, an operating margin of 13.9% and revenue up 8.0% year over year.
Its debt exceeds its cash by 13.89B USD, a debt-to-equity ratio of 2.14. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 18 analysts cover the stock; their mean price target of 311.89 USD is 24.5% above the current price. The next earnings report is expected on 11 February 2027.